Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fl udarabine, cyclophosphamide, rituximab) protocol;B-sejtes prolymphocytás leukaemia (B-PLL) sikeres kezelése FCR-Lite (fludarabin, cyclophosphamid, rituximab) protokoll alkalmazá sával

Orvosi Hetilap

Volumn 151, Issue 31, 2010, Pages 1261-1263

  Telek, Béla ^a   Batár, Péter ^a   Rejto, László ^a   Udvardy, Miklós ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

FCR Lite (fludarabine, cyclophosphamide, rituximab); prolymphocytic leukemia

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB;

AGED; B CELL PROLYMPHOCYTIC LEUKEMIA; CASE REPORT; HEMATOLOGY; HUMAN; IMMUNOPHENOTYPING; PROLYMPHOCYTIC LEUKEMIA; REMISSION; SHORT SURVEY; TREATMENT RESPONSE;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, PROLYMPHOCYTIC, B-CELL; MALE; PROGNOSIS; TREATMENT OUTCOME; VIDARABINE;

EID: 77955018179     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2010.28917     Document Type: Short Survey

References (9)

1. Galton, D. A. G., Goldman, J. M., Wiltshaw, E. és mtsai: Prolymphocytic leukaemia. Br. J. Haematol., 1974, 27, 7-23.
2. Dungarwalla, M., Matutes, E., Dearden, C. E.: Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur. J. Haematol., 2008, 80, 469-476.
3. Wattel, E., Preudhomme, C., Hecquet, B. és mtsai: p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignances. Blood, 1994, 84, 3148-3157.
4. Del Giudice, I., Davis, Z., Matutes, E. és mtsai: IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukaemia (B-PLL). Leukemia, 2006, 20, 1231-1237.
5. Shvidel, L., Shtalrid, M.., Bassous, M. és mtsai.: B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk. Lymphoma, 1999, 33, 169-179.
6. Kantarjian, H. M., Childs, C., OBrien, S. és mtsai: Effi cacy of fl udarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia. Am. J. Med., 1991, 90, 223-228.
7. Mourad, Y. A., Taher, A., Checal, A. és mtsa: Successful treatment of B-cell prolymphocytic leukaemia with monoclonal anti-CD20 antibody. Ann. Hematol., 2004, 83, 319-321.
8. Foon, K. A., Boyiadzis, M., Land, S. R. és mtsai: Chemoimmunotherapy with low dose fl udarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia. J. Clin. Oncol., 2009, 27, 498-503.
9. Tam, C. S., OBrien, S., Wierda, W. és mtsai: Long-term results of the fl udarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood, 2008, 112, 975-980.